What is the selling price of generic capmatinib in 2024?

The original drug Capmatinib (Capmatinib) is currently marketed and sold in many overseas countries. It is a drug used to treat a specific type of non-small cell lung cancer (NSCLC) that has spread to other parts of the body. Capmatinib belongs to a class of drugs called kinase inhibitors. It works by blocking the action of an abnormal protein that signals cancer cells to multiply. This helps slow or stop the spread of cancer cells.

It is understood that generic drugs of capmatinib are currently produced and sold in overseas markets. Its drug ingredients, specifications, and efficacy are basically the same as those of the original drug. There are some differences in the manufacturer and price. Common manufacturers of generic drugs include Laos Lucius Pharmaceutical Factory, Daxiong Pharmaceutical Factory, United Pharmaceutical Factory, and Element Pharmaceutical factories, etc., taking per box200mg*56 tablets as an example, the price may be more than more than 3,000 yuan. This price may also be affected by factors such as exchange rates and fluctuations.

Capmatinib is available as an oral tablet. It is usually taken twice daily with or without food. Take capmatinib at about the same time each day, and do not take more or less than your doctor prescribes. Patients may swallow the tablets whole; do not split, chew, or crush them. If you vomit after taking capmatinib, do not take another dose and continue with your regular dosing schedule.

Capmatinib is the first targeted therapy approved by the U.S. Food and Drug Administration (FDA) to treat aggressive lung cancer. During treatment, doctors may need to temporarily or permanently stop capmatinib treatment, or reduce its dose during treatment, depending on the drug's efficacy and side effects experienced by the patient. Capmatinib can be fatal to the fetus and it is recommended to avoid pregnancy and breastfeeding.